98 related articles for article (PubMed ID: 15662101)
1. Effects of chronic treatment with classic and newer antidepressants and neuroleptics on the activity and level of CYP2D in the rat brain.
Haduch A; Wójcikowski J; Daniel WA
Pol J Pharmacol; 2004; 56(6):857-62. PubMed ID: 15662101
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of rat liver CYP2D in vitro and after 1-day and long-term exposure to neuroleptics in vivo-possible involvement of different mechanisms.
Daniel WA; Haduch A; Wójcikowski J
Eur Neuropsychopharmacol; 2005 Jan; 15(1):103-10. PubMed ID: 15572279
[TBL] [Abstract][Full Text] [Related]
3. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain.
Haduch A; Bromek E; Daniel WA
Eur J Pharmacol; 2011 Jan; 651(1-3):51-8. PubMed ID: 21115002
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
Daniel WA; Haduch A; Wójcikowski J
J Pharm Pharmacol; 2002 Nov; 54(11):1545-52. PubMed ID: 12495558
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
Daniel WA; Syrek M; Haduch A; Wójcikowski J
Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
[TBL] [Abstract][Full Text] [Related]
6. Distribution interactions between perazine and antidepressant drugs. In vivo studies.
Wójcikowski J; Daniel WA
Pol J Pharmacol; 2000; 52(6):449-57. PubMed ID: 11334238
[TBL] [Abstract][Full Text] [Related]
7. Effects of classic and newer antidepressants on the oxidation pathways of caffeine in rat liver. In vitro study.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1045-53. PubMed ID: 14730100
[TBL] [Abstract][Full Text] [Related]
8. Influence of classic and atypical neuroleptics on caffeine oxidation in rat liver microsomes.
Daniel WA; Kot M; Wójcikowski J
Pol J Pharmacol; 2003; 55(6):1055-61. PubMed ID: 14730101
[TBL] [Abstract][Full Text] [Related]
9. Effect of mirtazapine on the CYP2D activity in the primary culture of rat hepatocytes.
Haduch A; Bromek E; Kot M; Jemnitz K; Veres Z; Vereczkey L; Daniel WA
Pharmacol Rep; 2006; 58(6):979-84. PubMed ID: 17220559
[TBL] [Abstract][Full Text] [Related]
10. The Atypical Antipsychotic Lurasidone Affects Brain but Not Liver Cytochrome P450 2D (CYP2D) Activity. A Comparison with Other Novel Neuroleptics and Significance for Drug Treatment of Schizophrenia.
Danek PJ; Daniel WA
Cells; 2022 Nov; 11(21):. PubMed ID: 36359909
[TBL] [Abstract][Full Text] [Related]
11. The effect of neuroleptics on brain tyrosine hydroxylase.
Rayevsky KS; Mineyeva MF; Kudrin VS
Ann Ist Super Sanita; 1978; 14(1):89-96. PubMed ID: 40504
[TBL] [Abstract][Full Text] [Related]
12. Interactions between promazine and antidepressants at the level of cellular distribution.
Daniel WA; Wójcikowski J
Pharmacol Toxicol; 1997 Dec; 81(6):259-64. PubMed ID: 9444666
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Treatment with Atypical Antipsychotic Iloperidone Modulates Cytochrome P450 2D (CYP2D) Expression and Activity in the Liver and Brain via Different Mechanisms.
Danek PJ; Daniel WA
Cells; 2021 Dec; 10(12):. PubMed ID: 34943983
[No Abstract] [Full Text] [Related]
14. Effects of several neuroleptics, antidepressants and monoamine uptake blockers on ATPase activity and related oxygen uptake in rat brain in vitro.
Velasco-Martín A; Garcia JL; Dueñas A
Methods Find Exp Clin Pharmacol; 1989 Dec; 11(12):737-41. PubMed ID: 2576298
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and histological effects of chronic antipsychotic and antidepressant drug treatment in aged rats with focal ischemic brain injury.
Zhao CS; Puurunen K; Schallert T; Sivenius J; Jolkkonen J
Behav Brain Res; 2005 Mar; 158(2):211-20. PubMed ID: 15698887
[TBL] [Abstract][Full Text] [Related]
16. The activity of brain and liver cytochrome P450 2D (CYP2D) is differently affected by antidepressants in the chronic mild stress (CMS) model of depression in the rat.
Haduch A; Rysz M; Papp M; Daniel WA
Biochem Pharmacol; 2018 Oct; 156():398-405. PubMed ID: 30195732
[TBL] [Abstract][Full Text] [Related]
17. Chronic treatment with asenapine affects cytochrome P450 2D (CYP2D) in rat brain and liver. Pharmacological aspects.
Danek PJ; Bromek E; Haduch A; Daniel WA
Neurochem Int; 2021 Dec; 151():105209. PubMed ID: 34666077
[TBL] [Abstract][Full Text] [Related]
18. Comparative neurochemical changes associated with chronic administration of typical and atypical neuroleptics: implications in tardive dyskinesia.
Bishnoi M; Kumar A; Chopra K; Kulkarni SK
Indian J Exp Biol; 2007 Feb; 45(2):175-9. PubMed ID: 17375557
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of ketamine elicits antidepressant-like effects in rats without affecting hippocampal brain-derived neurotrophic factor protein levels.
Garcia LS; Comim CM; Valvassori SS; Réus GZ; Andreazza AC; Stertz L; Fries GR; Gavioli EC; Kapczinski F; Quevedo J
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):502-6. PubMed ID: 19067677
[TBL] [Abstract][Full Text] [Related]
20. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
Larsen MH; Hay-Schmidt A; Rønn LC; Mikkelsen JD
Eur J Pharmacol; 2008 Jan; 578(2-3):114-22. PubMed ID: 17950272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
